Enflicoxib Size:Contact [email protected] for quotation 11-23(32)33)12-25(35)42-13-22-26(36)27(37)28(38)30(47-22)46-20-10-18-15(7-19(20)41-2)8-21(29(39)45-18)43-16-5-3-14-4-6-24(34)44-17(14)9-16/h3-10

11-23(32)33)12-25(35)42-13-22-26(36)27(37)28(38)30(47-22)46-20-10-18-15(7-19(20)41-2)8-21(29(39)45-18)43-16-5-3-14-4-6-24(34)44-17(14)9-16/h3-10

Cutamesine is a synthetic sigma receptor agonist which is selective for the σ1 receptor

Clematichinenoside AR alleviates foam cell formation and the inflammatory response in Ox-LDL-induced RAW264

roblitinib

Formula: C54H88O24

Enflicoxib Size:Contact [email protected] for quotation 11-23(32)33)12-25(35)42-13-22-26(36)27(37)28(38)30(47-22)46-20-10-18-15(7-19(20)41-2)8-21(29(39)45-18)43-16-5-3-14-4-6-24(34)44-17(14)9-16/h3-10Enflicoxib, also known as E 6087, is a cyclooxygenase 2 (COX 2) inhibitor potentially for the treatment of osteoarthritis and pain. E 6087 significantly enhanced the response to radiation, reducing mean volume to 32% of tumors treated with radiation only. The combination treatment neither increased apoptosis of tumor cells or stromal cells nor affected tumor microvascular density. In vitro, E 6087 and its active metabolite did not affect clonogenic